pneumonia
cap
third
caus
death
worldwid
marco
et
al
ruuskanen
et
al
although
agent
commonli
detect
adult
streptococcu
pneumonia
marco
et
al
new
high
sensit
techniqu
allow
detect
mani
respiratori
virus
associ
adult
cap
johnston
et
al
marco
et
al
mostli
influenza
viru
flu
johnston
et
al
luchsing
et
al
respiratori
syncyti
viru
rsv
luchsing
et
al
parainfluenza
viru
piv
henrickson
human
metapneumoviru
hmpv
luchsing
et
al
rhinoviru
rv
luchsing
et
al
human
coronaviru
hcov
johnston
et
al
luchsing
et
al
berri
et
al
also
detect
pathogen
role
controversi
human
bocaviru
hbov
rare
detect
adult
berri
et
al
appropri
manag
cap
requir
identif
potenti
etiolog
agent
antigen
detect
immunofluoresc
assay
ifa
routin
use
detect
respiratori
virus
children
good
perform
loeffelholz
chonmaitre
howev
highli
sensit
techniqu
must
use
adult
due
low
viral
shed
et
al
fox
loeffelholz
chonmaitre
real
time
revers
chain
reaction
nucleic
acid
amplif
method
use
diagnost
enhanc
viral
detect
high
sensit
new
methodolog
system
increas
diagnost
capac
allow
detect
mani
virus
time
fox
krunic
et
al
loeffelholz
chonmaitre
furthermor
commerci
kit
avail
rvp
assay
method
display
sensit
ifavir
cultur
merant
et
al
sensit
specif
gadsbi
et
al
howev
recent
studi
choudhari
et
al
sensit
rvp
pediatr
popul
wherea
sensit
convent
real
time
respect
adult
rvp
scantili
studi
studi
patient
divers
respiratori
ill
includ
et
al
costa
et
al
therefor
perform
adult
cap
unknown
sinc
rvp
perform
may
differ
differ
popul
cap
public
health
problem
necessari
establish
perform
pneumonia
optim
diagnosi
therefor
medic
manag
patient
type
sampl
affect
diagnost
techniqu
perform
varieti
differ
respiratori
sampl
method
nasal
oro
nasopharyng
wash
swab
aspir
appli
respiratori
virus
detect
discrep
result
ieven
lieberman
et
al
loeffelholz
chonmaitre
kim
et
al
irv
et
al
huijsken
et
al
jeong
et
al
compar
studi
diagnost
method
done
common
respiratori
virus
lieberman
et
al
even
fewer
done
adult
jeong
et
al
perform
sampl
vari
accord
detect
method
appli
sensit
npa
np
vari
children
accord
viru
detect
ieven
huijsken
et
al
thu
clinic
diagnost
influenc
pannel
respiratori
viru
search
sampl
method
use
aim
studi
compar
respiratori
virus
detect
luminex
rvp
ifa
adult
present
cap
secret
obtain
two
nasopharyng
secret
sampl
swab
aspir
studi
conduct
patient
year
age
present
cap
admit
three
public
hospit
universidad
de
chile
dr
lucio
san
one
privat
health
center
santa
santiago
chile
june
decemb
studi
approv
univers
health
institut
ethic
committe
subject
gave
written
inform
consent
enrol
cap
defin
presenc
acut
respiratori
symptom
less
week
chest
show
new
pulmonari
infiltr
exclus
criteria
includ
immunocompromis
condit
ie
human
immunodefici
viru
infect
activ
treatment
cancer
organ
transplant
immunosuppress
therapi
hospit
within
day
preced
enrol
inform
age
gender
prior
antibiot
treatment
diabet
mellitu
chronic
obstruct
pulmonari
diseas
asthma
cardiac
failur
liver
damag
renal
neurolog
diseas
record
patient
standard
file
chest
radiograph
pattern
describ
independ
radiologist
alveolar
interstiti
mix
infiltr
patient
sever
assess
first
hr
enrol
pneumonia
sever
index
psi
describ
fine
et
al
evalu
gender
age
neoplas
cardiac
respiratori
renal
ill
clinic
paramet
respiratori
rate
puls
etc
laboratori
paramet
hematocrit
partial
pressur
oxygen
pleural
effus
etc
accord
fine
score
patient
classifi
mild
score
sever
cap
score
total
respiratori
specimen
use
studi
nasopharyng
aspir
npa
nasopharyng
swab
np
npa
np
obtain
patient
time
sampl
obtain
day
admiss
use
plastic
tube
npa
flexibl
swab
brescia
itali
nurs
physic
therapist
staff
sampl
immedi
transport
ice
univers
transport
media
brescia
itali
laboratori
process
direct
simultan
ifa
nucleic
acid
extract
aliquot
also
store
smear
prepar
triplic
ifa
perform
rsv
adenoviru
adv
flu
piv
use
monoclon
antibodi
temecula
ca
hmpv
use
antibodi
temecula
ca
conjug
st
loui
mo
describ
elsewher
luchsing
et
al
total
nucleic
acid
extract
respiratori
sampl
sacac
kit
como
itali
accord
manufactur
instruct
real
time
revers
transcript
polymeras
chain
reaction
amplifi
fragment
differ
gene
adv
hbov
rsv
hmpv
piv
rv
hcov
use
arvi
screen
kit
ab
influenza
virus
influenza
b
kit
accord
manufactur
instruct
sacac
except
volum
proport
te
buffer
cdna
revers
transcript
step
perform
appli
austria
thermal
cycler
multiplex
rtpcr
rotor
australia
real
time
thermal
cycler
detect
rsv
hmpv
rventeroviru
rvev
piv
type
one
four
adv
hbov
flu
flu
b
hcov
perform
luminex
respiratori
viral
panel
fast
kit
corp
toronto
canada
luminex
accord
instruct
brief
techniqu
nucleic
acid
amplifi
use
pcr
label
short
sequenc
tag
primer
dna
specif
viral
target
lengthen
target
specif
primer
extens
tspe
bead
sequenc
specif
join
tag
primer
identifi
laser
comparison
group
test
use
quantit
variabl
exact
fisher
test
categor
variabl
sensit
specif
predict
kappa
valu
rvp
calcul
use
result
refer
assay
routin
method
receiv
oper
characterist
curv
roc
area
curv
auc
viral
detect
rvp
ifa
calcul
level
signific
set
p
analys
perform
use
graphpad
san
diego
ca
stata
version
softwar
colleg
station
tx
hospit
adult
cap
enrol
includ
analys
test
rvp
fast
median
age
year
rang
male
ratio
virus
detect
case
patient
without
viral
detect
similar
age
median
year
rang
year
gender
male
vs
p
day
evolut
median
vs
rang
day
p
sever
cap
sever
p
significantli
frequent
group
without
viral
detect
vs
p
hypertens
frequent
group
respect
p
other
frequent
condit
patient
without
viral
detect
chronic
obstruct
pulmonari
diseas
respect
p
diabet
mellitu
respect
p
patient
studi
virus
detect
rvp
fast
p
patient
test
posit
rv
flu
ab
six
rsv
three
adv
three
piv
three
hmpv
one
hcov
six
case
two
virus
detect
rv
flu
adv
flu
adv
hbov
patient
test
posit
rv
flu
ab
five
rsv
four
piv
four
hmpv
two
adv
two
hcov
one
hbov
nine
case
two
virus
detect
rv
adv
hbov
hcov
four
flu
b
p
number
respiratori
specimen
test
npa
np
patient
type
sampl
among
virus
detect
p
fulli
concord
observ
specimen
ident
posit
result
neg
result
assay
overal
rate
concord
good
kappa
coeffici
fourteen
sampl
posit
rvp
fast
viral
detect
discord
specif
viru
posit
rate
rvp
statist
differ
concord
rang
fair
hcov
perfect
rsv
tabl
ifa
detect
virus
patient
significantli
lower
p
npa
test
rvp
fast
sampl
posit
p
agre
case
posit
neg
auc
versu
two
virus
sampl
detect
four
case
seven
rvp
fast
total
viral
detect
respect
tabl
rhinoviru
common
agent
detect
method
perform
rvp
fast
use
assay
routin
method
agent
overal
detect
provid
tabl
ii
although
detect
rate
viru
similar
npa
test
p
discord
case
tabl
si
compris
virus
addit
detect
rvp
fast
nine
extra
detect
rvp
eleven
two
hcov
two
piv
one
adv
hbov
hmpv
mean
fluoresc
intens
mif
extra
detect
five
rv
one
viru
piv
flu
b
hcov
adv
cycl
threshold
ct
tabl
si
ifa
detect
two
flu
virus
one
rsv
npa
np
test
real
time
virus
detect
rvp
p
agre
posit
neg
sampl
auc
vs
two
virus
detect
one
patient
two
increas
viral
detect
respect
p
tabl
rhinoviru
agent
commonli
detect
tabl
perform
rvp
fast
show
tabl
ii
although
detect
rate
viru
similar
np
p
virus
addit
posit
eight
rv
one
adv
one
piv
rvp
fast
eleven
two
flu
one
hmpv
one
tabl
sii
total
patient
discord
viral
detect
posit
case
neg
ct
opposit
situat
mif
tabl
sii
ifa
detect
flu
rsv
one
case
one
np
test
rate
detect
overal
posit
rate
npa
higher
np
method
p
rvp
p
respect
overal
viral
detect
npa
np
p
detect
virus
npa
np
p
patient
pair
npa
np
test
posit
rate
npa
np
p
result
concord
neg
posit
case
flu
flu
b
rv
rsv
one
one
adv
hcov
hmpv
hbov
two
case
virus
identifi
type
sampl
differ
flu
npa
rv
np
one
case
npa
rv
np
anoth
adult
virus
detect
np
six
npa
includ
rv
one
flu
three
adv
one
coinfect
rv
anoth
piv
rv
two
case
flu
rv
hbov
also
detect
npa
npa
np
patient
test
rvp
fast
six
posit
sampl
six
npa
three
np
thu
posit
rate
npa
np
p
kappa
coeffici
match
viral
detect
two
two
hmpv
one
flu
one
hbov
one
flu
one
case
hbov
detect
addit
npa
one
one
hcov
one
piv
detect
np
adult
cap
case
herein
studi
overal
respiratori
virus
detect
rate
new
luminex
rvp
fast
techniqu
similar
vs
p
agre
previou
public
children
adult
global
respiratori
infect
consequ
includ
routin
laboratori
test
due
high
frequenc
viral
detect
patient
confirm
relev
role
virus
adult
pneumonia
henrickson
johnston
et
al
marco
et
al
ruuskanen
et
al
luchsing
et
al
contrari
poorer
perform
ifa
assay
p
confirm
ineffect
respiratori
virus
detect
adult
liolio
et
al
legoff
et
al
lee
et
al
fox
ieven
ginocchio
et
al
gadsbi
et
al
although
lower
cost
easi
implement
explain
wide
use
addit
ifa
oper
depend
detect
five
virus
wherea
rvp
abil
test
much
virus
run
mani
sampl
simultan
thu
although
expens
techniqu
worth
applic
consid
shorten
patient
treatment
hospit
stay
mahoni
et
al
dunda
et
al
good
perform
rvp
regard
observ
npa
np
sensit
rang
describ
popul
pabbaraju
et
al
gadsbi
et
al
methodolog
pabbaraju
et
al
jokela
et
al
popowitch
et
al
howev
virus
detect
spite
nucleic
acid
extract
test
techniqu
uniqu
extract
method
kit
appli
assum
differ
extract
method
test
influenc
result
krunic
et
al
complet
rule
verheyen
et
al
discrep
result
might
also
explain
better
primer
target
perform
immedi
collect
extract
use
rvp
frozen
order
enough
number
sampl
reduc
cost
thu
sampl
low
viral
load
accord
high
ct
could
lost
rna
thaw
result
neg
howev
fact
explain
discrep
two
case
show
ct
detect
ct
nine
rv
detect
method
rvp
specif
lower
publish
popul
methodolog
pabbaraju
et
al
gadsbi
et
al
et
al
jokela
et
al
sinc
rvp
distinguish
rv
ev
differ
could
due
extra
case
ev
detect
gadsbi
et
al
extra
detect
virus
might
fals
posit
least
two
four
case
flu
confirm
convent
sampl
previous
obtain
hospit
clinic
practic
relev
establish
best
type
respiratori
sampl
viral
detect
author
recommend
np
npa
easier
obtain
better
viral
detect
loeffelholz
chonmaitre
experi
viral
detect
significantli
higher
npa
np
techniqu
less
viru
detect
np
npa
furthermor
viral
detect
either
method
np
compar
npa
even
though
sampl
could
complementari
combin
would
increas
detect
rate
would
justifi
given
addit
case
np
rhinoviru
recov
upper
respiratori
tract
whose
pathogenesi
cap
debat
luminex
rvp
appropri
assay
nasopharyng
aspir
optim
type
respiratori
sampl
detect
respiratori
viru
adult
cap
studi
approv
univers
health
institut
ethic
committe
